Skip to main content

We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.

NHF will update this page as more statements become available.

Industry Forms Alliance to Develop Potential Treatment for Patients with Serious COVID-19 Complicati

Developing such a treatment would necessitate plasma donations from many people who have fully recovered from COVID-19, and whose blood contains antibodies that can fight the coronavirus.

Comment Period for VWD Clinical Practice Guidelines Open

NHF is seeking comments on draft ASH ISTH NHF WHF clinical practice guidelines on VWD Diagnosis & Management.

APLUS Statement on FDA Policy Changes Related to Blood and Plasma Donation

NHF and HFA are members of the American Plasma Users Coalition.

The FDA approval is for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.

Subscribe to Our Newsletter

Fill in the fields below to receive our email newsletter.


OUR ADVERTISERS